Product Information | |
---|---|
Product Name | Human gastric adenocarcinoma cells (AGS-EGFP) |
Specifications | 1*10^6 |
Storage and transportation | Dry ice preservation/T25 live cell transportation. |
Cell name | AGS-EGFP |
Cell morphology | Epithelioid, adherent cell |
Passage ratio | 1:2~1:4 |
species | Human |
Construction method | Virus Method |
Mycoplasma testing | negative |
Cultivation System | 90% F12K+10% FBS |
Introducing AGS-EGFP human gastric adenocarcinoma cells uniquely engineered for optimal research and therapeutic applications; these epithelioid adherent cell lines are preserved using dry ice for reliable transportation and storage providing a dynamic platform for exploring cancer biology and advancing oncology research with a negative virus method and high viability in a 90% F12K + 10% FBS culture medium
The Human gastric adenocarcinoma cells (AGS-EGFP) represent a pivotal tool in cancer research particularly for studying the biology of gastric cancer via their unique fluorescent tagging that allows for real-time observation of cellular processes These adherent and epithelioid cells are preserved in dry ice ensuring viability during transportation or storage thus enabling researchers to perform critical experiments in various geographical locations without compromise to the integrity of the samples
In therapeutic development AGS-EGFP cells are essential for screening new anti-cancer drugs providing insights into their efficacy and mechanisms of action against human gastric cancer cells Additionally these cells can be utilized for the investigation of cellular responses to viral infections providing a platform to explore potential treatments for viral-related cancers while maintaining a negative viral history ensuring that observations are solely related to gastric adenocarcinoma
With nutrients provided through a specialized medium of 90% F12K and 10% FBS AGS-EGFP cells thrive during experimentation facilitating in-depth studies into gene expression and signal transduction pathways that drive the progression of cancer Their carefully controlled culture conditions lend themselves to reproducibility in research making AGS-EGFP a reliable resource for both academic and pharmaceutical initiatives focused on combating gastric cancer
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.